These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30272152)

  • 1. Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Eur Heart J; 2018 Nov; 39(43):3905. PubMed ID: 30272152
    [No Abstract]   [Full Text] [Related]  

  • 2. More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
    Fett JD
    Eur Heart J; 2018 Nov; 39(43):3904. PubMed ID: 30272149
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
    Hilfiker-Kleiner D; Sliwa K; Bauersachs J
    Eur Heart J; 2018 Oct; 39(37):3478. PubMed ID: 30016421
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to '12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy'.
    Hoevelmann J; Viljoen CA; Millar RS; Manning K; Ntsekhe M; Sliwa K
    Int J Cardiol; 2019 Dec; 297():91. PubMed ID: 31431295
    [No Abstract]   [Full Text] [Related]  

  • 5. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
    Arrigo M; Blet A; Mebazaa A
    Eur Heart J; 2017 Sep; 38(35):2680-2682. PubMed ID: 28934838
    [No Abstract]   [Full Text] [Related]  

  • 6. Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
    Ersbøll AS; Arany Z; Gustafsson F
    Eur Heart J; 2018 Oct; 39(37):3476-3477. PubMed ID: 30016425
    [No Abstract]   [Full Text] [Related]  

  • 7. A de-novo deletion of dystrophin provoking severe 'peri-partum cardiomyopathy': The importance of genetic testing in peripartum cardiomyopathy to uncover female carriers.
    Ahmed A; Spinty S; Murday V; Longman C; Khand A
    Int J Cardiol; 2016 Jan; 203():1084-5. PubMed ID: 26651149
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump.
    Schroeter MR; Unsöld B; Holke K; Schillinger W
    Clin Res Cardiol; 2013 Feb; 102(2):155-7. PubMed ID: 22829017
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripartum Cardiomyopathy. Reply.
    Arany Z
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631015
    [No Abstract]   [Full Text] [Related]  

  • 10. Authors' reply re: Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.
    Guldbrandt Hauge M; Johansen M; Vejlstrup N; Gustafsson F; Damm P; Ersbøll AS
    BJOG; 2018 Jul; 125(8):1040-1041. PubMed ID: 29479809
    [No Abstract]   [Full Text] [Related]  

  • 11. An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
    Nicholls M
    Eur Heart J; 2016 Nov; 37(44):3313-3314. PubMed ID: 28007932
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
    Kryczka KE; Demkow M; Dzielinska Z
    Ginekol Pol; 2021; 92(2):147-152. PubMed ID: 33084016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peripartum cardiomyopathy].
    Bretler DM; Jørgensen CH; Olesen JB; Gislason GH; Hansen PR
    Ugeskr Laeger; 2009 Jan; 171(1-2):53-5. PubMed ID: 19128569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caution in the use of bromocriptine in peripartum cardiomyopathy.
    Fett JD
    J Am Coll Cardiol; 2008 May; 51(21):2083; author reply 2083-4. PubMed ID: 18498970
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripartum Cardiomyopathy.
    Gleicher N
    N Engl J Med; 2024 Apr; 390(15):1443. PubMed ID: 38631014
    [No Abstract]   [Full Text] [Related]  

  • 16. Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Aug; 38(8):423-4. PubMed ID: 27583690
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Prolactin Inhibition in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Sep; 38(9):477-478. PubMed ID: 27658008
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripartum cardiomyopathy: diagnosis and management.
    Jackson AM; Dalzell JR; Walker NL; Coats CJ; Jhund PS; Petrie MC
    Heart; 2018 May; 104(9):779-786. PubMed ID: 29122930
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Triebel J; Clapp C; Bertsch T
    Rev Bras Ginecol Obstet; 2016 Nov; 38(11):580-582. PubMed ID: 27875851
    [No Abstract]   [Full Text] [Related]  

  • 20. 12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy.
    Tak BT; Cetin EHO; Ulvan N; Cay S; Aras D
    Int J Cardiol; 2019 Oct; 293():185. PubMed ID: 31447034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.